Transgene Biotek LimitedBSE: TRABI

Board Meeting Outcome for Outcome Of The Board Meeting

· Issued by Transgene Biotek Limited via BSE India

Filed with BSE ·

1)The Board considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025. 2)The Board considered and approved the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025. 3)The Board considered and approved the extension of the date of Annual General Meeting (AGM) of the Company for the financial year 2024-25.4)The Board considered and approved the appointment of M/s.Manisha Dubey & Associates, as Internal Auditors of the Company for the financial year 2025-26. 5)The Board considered and approved the appointment of M/s. Geeta Serwani & Associates, Practicing Company Secretaries as Secretarial Auditor of the Company for the term of 5 years effective from 01st April 2025 till 31st March 2030 which is subject to regularization by shareholders at AGM; The meeting commenced at 11.00 A.M and concluded at 11.45A.M.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Transgene Biotek Limited on 6ix

Earlier from Transgene Biotek

Later from Transgene Biotek

All Transgene Biotek news releases